Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Ocular Therapeutix ( (OCUL) ) is now available.
Ocular Therapeutix, Inc. has recently expanded its 2019 Inducement Stock Incentive Plan, enabling the issuance of an increased number of shares to motivate and retain employees. The amendment, adopted by the board on October 4, 2024, ups the total available shares from 4,804,000 to 6,054,000, demonstrating the company’s commitment to leveraging stock-based incentives to drive growth and success.
Find detailed analytics on OCUL stock on TipRanks’ Stock Analysis page.

